Taking everything into account, KRYS scores 6 out of 10 in our fundamental rating. KRYS was compared to 525 industry peers in the Biotechnology industry. KRYS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. KRYS is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year KRYS was profitable.
KRYS had a positive operating cash flow in the past year.
In multiple years KRYS reported negative net income over the last 5 years.
KRYS had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

KRYS has a Return On Assets of 16.04%. This is amongst the best in the industry. KRYS outperforms 95.81% of its industry peers.
With an excellent Return On Equity value of 17.48%, KRYS belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
The Return On Invested Capital of KRYS (12.28%) is better than 95.24% of its industry peers.

		Industry Rank	Sector Rank
ROA	16.04%
ROE	17.48%
ROIC	12.28%

ROA(3y)-5.09%

ROA(5y)-7.35%

ROE(3y)-5.33%

ROE(5y)-7.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 53.30%, KRYS belongs to the top of the industry, outperforming 98.48% of the companies in the same industry.
Looking at the Operating Margin, with a value of 42.40%, KRYS belongs to the top of the industry, outperforming 99.24% of the companies in the same industry.
KRYS has a better Gross Margin (94.26%) than 94.67% of its industry peers.

		Industry Rank	Sector Rank
OM	42.4%
PM (TTM)	53.3%
GM	94.26%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

KRYS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KRYS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for KRYS has been increased compared to 5 years ago.
There is no outstanding debt for KRYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

KRYS has an Altman-Z score of 49.42. This indicates that KRYS is financially healthy and has little risk of bankruptcy at the moment.
KRYS has a better Altman-Z score (49.42) than 96.00% of its industry peers.
There is no outstanding debt for KRYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	49.42

ROIC/WACC1.38

WACC8.88%

2.3 Liquidity

KRYS has a Current Ratio of 10.14. This indicates that KRYS is financially healthy and has no problem in meeting its short term obligations.
KRYS has a better Current ratio (10.14) than 81.14% of its industry peers.
KRYS has a Quick Ratio of 9.73. This indicates that KRYS is financially healthy and has no problem in meeting its short term obligations.
KRYS has a better Quick ratio (9.73) than 80.38% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.14
Quick Ratio	9.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KRYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 276.84%, which is quite impressive.
KRYS shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.51%.

EPS 1Y (TTM)276.84%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%192.31%

Revenue 1Y (TTM)54.51%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%16.65%

3.2 Future

Based on estimates for the next years, KRYS will show a very strong growth in Earnings Per Share. The EPS will grow by 58.10% on average per year.
The Revenue is expected to grow by 31.67% on average over the next years. This is a very strong growth

EPS Next Y114.44%

EPS Next 2Y64.64%

EPS Next 3Y46.4%

EPS Next 5Y58.1%

Revenue Next Year34.01%

Revenue Next 2Y38.02%

Revenue Next 3Y36.66%

Revenue Next 5Y31.67%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 42.21, which means the current valuation is very expensive for KRYS.
91.24% of the companies in the same industry are more expensive than KRYS, based on the Price/Earnings ratio.
KRYS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.21.
With a Price/Forward Earnings ratio of 34.74, KRYS can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, KRYS is valued cheaper than 91.62% of the companies in the same industry.
KRYS is valuated rather expensively when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	42.21
Fwd PE	34.74

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRYS is valued cheaper than 91.62% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KRYS indicates a rather cheap valuation: KRYS is cheaper than 92.76% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	49.31
EV/EBITDA	43.47

4.3 Compensation for Growth

KRYS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KRYS may justify a higher PE ratio.
KRYS's earnings are expected to grow with 46.40% in the coming years. This may justify a more expensive valuation.